ArticleCureus2024
A Case Report on a Common Tumour With an Uncommon Presentation: Glioblastoma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The most common type of primary brain tumour in adults is gliomas although rare. Glioblastomas are a subtype of gliomas with the worst prognosis having the ability to rapidly increase in size, even doubling within days to weeks. Patients can present with varied presentations depending on the site of the involvement, thus misleading in diagnosis due to vagueness. The most common clinical presentations include headaches, seizures, and focal neurological signs. However, there can be atypical presentations like personality changes and back pain due to meningeal irritation which may be the only presenting complaint in the early stages. Magnetic resonance imaging (MRI) is usually considered the only investigation required for the diagnosis of the illness. However, it can mislead in the early stages. Therefore, brain biopsy remains the gold standard in the diagnosis of glioblastoma multiforme. It is important to identify the subtype to decide on the prognosis and plan the management thereafter. Here, we present a 49-year-old woman with prominent personality changes, depressive symptoms, and atypical brain imaging findings. The definitive diagnosis was made with the brain biopsy as two MRI findings were contradictory. This article highlights the importance of suspicion of primary brain tumours in adults presenting with atypical neuropsychiatric manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.